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Summary: The determination of -amylase with 2-chloro-4-nitrophenyl-ß-Z)-maltoheptaoside äs Substrate
was evaluated. The molar lineic absorbance of the liberated product, 2-cliloro-4-nitrophenol, depends on the
concentration of the protein present in the test. The catalytic activity concentrations obtained with human
native sera, urines and commercial test sera were compared with activity concentrations determined using
Substrates with the same carbohydrate chain length. The analytical agreement is acceptable for human sera
and urines.
The relative reaction rates measured with -amylase of various origins and 7 different Substrates are presented.
The advantages of the new test are discussed.
Bestimmung von -Amylase mit 2^Chlor-4-nitrophenyl-ß-D-maltoheptaosid als Substrat: Ein Methodenvergleich
Zusammenfassung: Die Methode zur Bestimmung von -Amylase mit 2-Chlor-4-nitrophenyl-ß-/)-maltohep-
taosid als Substrat wurde evaluiert. Die molare lineare Absorbanz des freigesetzten 2-Chlor-4-nitrophenol
hängt von der im Testansatz vorliegenden Proteinkonzentration ab. Mit dieser Methode und mit Methoden,
die Substrate gleicher Kphlenhydrät-Kettenlänge verwenden, in frischem menschlichen Serum, Harn und
kommerziell erhältlichen Testseren bestimmte kätalytische Konzentrationen werden miteinander verglichen.
Die analytische Übereinstimmung ist für menschliche Seren und Harne annehmbar.
Die mit -Amylase unterschiedlicher Herkunft und sieben verschiedenen Substraten gemessenen relativen
Reaktionsgeschwindigkeiten werden mitgeteilt. Die Vorzüge des neuen Tests werden erörtert.
i Introduction , . _ , , . . , ,
 ö ,j .. * -amylase is 2-chloro-4-mtrophenyl-ß-Z)-malto-
j The introduction of the chromogenic endpoint heptaoside (9). The increase of the absorbance of
! methods (l, 2) has given a new impetus to the de- 2-chloro-4-nitrophenol at 405 nm can be measured.
! termination of the activity concentration of c^amy- The interesting advantage of this method is reported
j läse (l,4-a^/)-glucan glucanohydrolase, EC 3.2.1.1). to be that the liberated product is insensitive to
i Othef procedures and other Substrates, such äs a changes both in temperature and pH under assay
blocked starch molecule (3), maltotetraose (4, 5), conditions. In this communication we present a short
maltoheptaose (6), 4-nitrophenylmaltoheptaoside (7), evaluation of this method, together with a com-
and a mixture of 4-nitrophenylmaltopentaoside and parison with some other methods for the de-
i -hexaoside (8), have been introduced. The most re- termination of the activity concentration of a-amy-
! cently developed Substrate for the determination of läse.
i
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Materials and Methods
All dcterminations were carricd out at 37 °C on a spectro-
photomcter (Beckman; modei 25).
The kits for the dctermination of -amylase with 2-chloro-4-
nitrophenylmallohcptaoside were a gift of E. Merck Nederland
B. V. Amsterdam, The Netherlands, The determinations and
calculations were carried out exactly according to the in-
structions of the manufacturer.
Other determinations vvere carried out with the following sub-
strates: 4-nitrophenylmaltoheptaoside (Boehringer Mannheim
GmbH, FRG); maltoheptaose (a gift from Boehringer
Mannheim B. V., AJmere, The Netherlands); maltotetraose (In-
struchemie, Hilversum, The Netherlands); a mixture of 4-nitro-
phenylmaltopentaoside and -hexaoside (Testomar, Beh-
ringwerke AG Marburg, FRG); blocked starch molecule and
Phadebas blue starch (both from Phadebas, Diagnostics AB,
Uppsala, Sweden).
2-Chloro-4-nitrophenol was a gift from E. Merck Nederland
B. V. Amsterdam, The Netherlands, and 4-nitrophenol was
purchased from British Drug House (BDH), Brunschwig,
Amsterdam, The Netherlands. All other chemicals were of
reagent grade. Venous blood was sampled from normal vol-
unteers and after clotting it was centrifuged. The determinations
were carried out äs soon äs possible; otherwise the serum was
stored at — 20 ÖC. Urine was collected äs usually.
-Amylase from pig pancreas and -amylase from Bacillus
subülis were purchased from Boehringer Mannheim B. V.,
Almere, The Netherlands.
Human pancreatic -amylase was obtained from duodenal fluid
(10) and human salivary -amylase from saliva. Enzyme pre-
parations were diluted with a dilution fluid äs described eaflier
(10). The reconstitution of the freeze dried sera was carried out
äs prescribed by the manufacturers.
All catalytic activity concentrations are expressed in U/l.
Results and Discussion
Table l shows the effect of increasing protein con-
centrations on the molar lineic absorbance of 2-
chloro-4-nitrophenol and 4-nitrophenol at two dif-
ferent buffer concentrations and two different pH
values. These conditions were chosen according to
Tab. 1. Influence of albumin on the molar lineic absorbance
of 2-chloro-4-nitrophenol and 4-nitrophenol at 405 nm
and 37 °C.
Albumin
(g/l)
0
0.4
0.8
1.6
3.2
Molar lineic absorbance
2-Chloro-4- 4-Nitro-
nitrophenol phenol
50 mmol/1 phosphate,
pH 6.8
1590 671
1540 674
1460 675
1430 678
1410 702
(m2 x mol-1)
2-Chloro-4- 4-Nitro-
nitrophenol phenol
100 mmol/1 phosphate,
pH 7.1
1730 993
1630 971
1600 943
1550 919
1530 851
the specifications of the suppliers for 2-chloro-4^
nitrophenylmaltoheptaoside and 4-nitrophenyl-
maltoheptaoside respectively. Except for 4-nitro-
phenol in 50 mmol/1 phosphate buffer at pH 6.8, it is
obvious that the molar lineic absorbance decreases
with increasing protein concentration. At the highest
concentration of albumin about 86% of the original
value without albumin was found. Moreover, Jung &
Köhler (11) observed a decrease in molar lineic
absorbance of 4-nitrophenol at 405 nm in di-
ethanolamine buffer but not in NaOH. The present
studies show that results for the determination of a-
amylase with 2*chloro-4-iutrophenylmaitoheptaoside
äs Substrate also depend on the protein concentration
during the reaction. We used for ouf calculations a
molar lineic absorbance value of 1660 m2 · mol"1 äs
indicated by the manufacturer. Henkel et al (9) have
already pointed qiit that the molar lineic absorbance
of 2-chloro-4rnitrophenol is independent of the
temperature, in contrast to the data for 4^nitrophenol
(H, 12).
We compared results for the measurement of a^-amy-
lase using 2-chloro^nitrophenylmaltoheptaoside äs
Substrate with those from the üse of Substrates of the
same cärbohydrate chain length äs in 2-chloro-4-
nitrophenylmaltoheptaoside. The catalytic activity
concentrations determined with 2-chloro-4-nitro-
phenylmaltoheptaoside äs Substrate were divided by
the catalytic activity concentrations obtained with 4-
nitrophenylmaltoheptaoside äs Substrate. These
quotients obtairied for native human sera, urines,
test sera and -amylase from pig pancreas, human
pancreatic fluid, human saiiva and Bacillus subtilis
are given in figure l. For native sera these quotients
are equal to l, which means that both Substrates, 2-
chloro-4-nitrophenylmaltoheptaoside and 4-nitro-
phenylmaltoheptaoside, are converted at the same
rate by -amylase in human serum. The same holds
for human urines. The quotients ränge from 0.64 to
1.52 for various test sera and are also quite different
for the various -amylase preparations. A ratio of
about 0.7 was obtained for 18 controi sera. This ratio
is equal to the ratio of 0.71 for -amylase from pig
pancreas. So it is possible that these controi sera have
been enriched with -amylase from pig pancreas.
Figure 2 demönstrates the ratio obtained for the
catalytic activity concentrations measured with 2-
chloro-4-mtrophenylmaltoheptaoside and malto-
heptaose äs Substrate. The ratio for human native
sera and urines is about 1.0 to 1.1 For the controi
sera, the ratio ranges from 0.13 to 1.28, a difference
of a factor 10. The ratio for -amylase from Bacillus
subtilis is much higher than for the other -amylase
preparations. * »·
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Fig. 1. Ratio of catalytic activity concentrations of a-amylase
obtained with 2-chloro-4-nitrophenylmaltoheptaoside
and 4-nitrophenylmaltoheptaoside s Substrates.
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Fig. 2. Ratio of catalytic activity concentrations of a-amylase
obtained with 2-chloro-4-nitrophenylmaltoheptaoside
and maltoheptaose s Substrates.
The ratio obtained for the catalytic activity con-
centrations measured with 4-nitrophenyl-
maltoheptaoside and maltoheptaose s Substrate is
shown in figure 3. Again a ratio of about 1.0 was
observed for human sera and urines and a very dif-
ferent ratio for control sera and the α-amylase pre-
parations.
Table 2 demonstrates the relative reaction rates of a-
amylase from Bacillus subtilis, human pancreatic
fluid, human saliva and pig pancreas. The reaction
rate for each of the preparations of a-amylase
obtained with the blue starch method was fixed at
l .00, and the other reaction rates were calculated s
fraction of the value. The lowest reaction rate for all
α-amylases tested was obtained with maltotetraose s
the Substrate; values varied from 0.00005 for a-amy-
lase from Bacillus subtilis to 0.221 for the enzyme
from human saliva. An increase of the carbohydrate
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Fig. 3. Ratio of catalytic activity concentrations of a-amylase
obtained with 4-nitrophenylmaltoheptaoside and
maltoheptaose s Substrates.
Tab. 2. Relative reaction rates of the determination reaction of α-amylase carried out with different Substrates. The catalytic
activity concentrations were expressed in U/1 and afterwards the blue starch method was set at 1.000.
..
Substrate
Maltotetraose
4-Nitrophenylmaltopentaoside/-maltohexaoside
Maltoheptaose
4-Nitrophenylmaltoheptaoside
2-Chloro-4-nitrophenylmaltohsptaoside
Blocked starch
Blue starch
a-Amylase
Bacillus
subtilis
0.00005
0.00081
0.036
0.095
0.123
0.307
1.000
from
Human
pancreatic
fluid
0.154
0.199
0.615
0.612
0.600
1.178
1.000
Human
saliva
0.221
0.278
0.706
0.722
0.674
1.077
1.000
Pig
pancreas
0.114
0.667
1.618
1,529
1.040
1.417
1.000
Ratio
Human pancreatic fluid
Human saliva
0.70
0.72
0.87
0.85
0.89
1.09
1.00
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chain of the Substrate increases the reaction rate of
-amylase from Bacillus subtilis. The highest reaction
rate for the bacterial -amylase was obtained when
blue starch was the Substrate, this cornpound being
the largest molecule of all Substrates tested.
When -amylase of human origin was tested, the
reaction rate with maltotetraose or a mixture of 4-
nitrophenylmaltopentaoside and -hexaoside äs sub-
strate, was obviously low. Moreover, the reaction rate
was about the same with both Substrates, in contrast
to -amylase from Bacillus subtilis or from pig pan-
creas. An increase of the carbohydrate chain to 7
glucose units (maltoheptaose, 4-nitrophenyl-
maltoheptaoside or 2-chloro-4-nitrophenylmalto-
heptaoside) increases the reaction rate, while the
differences between these 3 Substrates are very low.
So it seems that the presence of 4-nitrophenol or 2-
chloro-4-nitrophenol in 4-nitrophenylmaltohepta-
oside or 2-chloro-4-nitrophenylmaltoheptaoside does
not influence the reaction rate of either of these
human -amylases. The highest relative reaction rates
were obtained when the blocked starch or the blue
starch molecule was used äs Substrate. Again the
reaction rates are about the same for both human a-
amylases, in contrast to bacterial or pig -amylase.
As far äs -amylase from pig pancreas is concerned
the lowest reaction rate was again obtained with
maltotetraose äs Substrate. The reaction rate was
enhanced by increasing the carbohydrate chain of the
Substrate. There was a difference between the relative
reaction rates when the 3 Substrates maltoheptaose,
4-nitrophenylmaltoheptaoside or 2-chloro-4-nitro-
phenylmaltoheptaoside were used, the reaction rate
being much lower for 2-chloro-4-nitrophenyl-
maltoheptaoside. The highest relative reaction rate
was observed when blocked starch, maltoheptaose or
4-nitrophenylmaltoheptaoside served äs the sub-
strates. Apparently an entity of 7 to 9 molecules of
glucose is the most suitable Substrate for -amylase
from pig pancreas, except when 2-chloro-4-nitro-
phenylmaltoheptaoside is used äs Substrate. It may
be that the additionally introduced chlorine atom has
some inhibitory influence on the catalytic activity of
pig pancreatic -amylase, or the active center of the
enzyme is different from that of human -amylase.
From the ratio, pancreatic to salivary -amylase, it
can be concluded that an increase of the carbohydrate
chain of the Substrate favours the action of the
pancreatic isoenzyme. These results are in agreement
with those of Meier et al. (13), Sampson et al. (14)
and Lorentz (15). Apparently ar^mylase attacks not
only different Substrates in a different way, but also
one Substrate can be attacked in various ways by a-
amylase of different origin.
Generally it can be concluded that this new test for
the determination of -amylase is good, präcticäl and
reliable äs far äs the determination öf -amylase from
human serum and urine is concerned. The test is
pH-independent in the normal rneasuring ränge (in
contrast to the kit with 4-nitrophenylmältoheptaoside
äs Substrate), and it is also temperature independent,
äs described earlier (9). The assay is influenced by the
protein concentration. The molar lineic absorbance
depends on the reaction conditions and systematic
errors of about 10% are present when no allowance
is made for the influenee of the reaction coriditiöns.
The test with 2-chloro-4-nitrophenylmaltoheptaoside
äs Substrate is more sensitive than the test with 4-
nitrophenylmaltoheptaoside, and it needs less sample
volume. The Substrate is completely comparable with
other Substrates havitig the same length of the car-
bohydrate chain, except when pig pancreatic -amy-
lase is the enzyme to be measured.
Lorentz (16) has formulated four essentials for the
basis of a recommended method for -amylase meas-
urement. In ouf vieW, -2-chloro-4-nitrophenyl-
maltoheptaoside fulfils most of the essentials, except
for the fact that a lag phase is present at the Start of
the reaction.
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